AKT1 and ovarian cancer: In conclusion, we show that pharmacological inhibition or genetic ablation of PI3K/AKT during REP stage of TIL in cervical and ovarian cancer promotes the propagation of tumor‐reactive TIL with memory‐like phenotype.